MIRA INFORM REPORT
|
Report No. : |
323845 |
|
Report Date : |
25.05.2015 |
IDENTIFICATION DETAILS
|
Name : |
AGOG PHARMA LIMITED |
|
|
|
|
Formerly Known
As : |
AGOG PHARMA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Plot No.33, Sector-II, The Vasai Taluka Industrial Co-Operative Estate
Limited, Gauripada, Vasai (East), Thane - 401208, Maharashtra |
|
Tel. No.: |
91-95250-2455801 / 2452714 / 2453525 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2014 |
|
|
|
|
Date of
Incorporation : |
20.12.1990 |
|
|
|
|
Com. Reg. No.: |
11-059515 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 31.500 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24230MH1990PLC059515 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
Not Available |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged in the business of chemist, druggists,
importer and manufacturer of and dealers in pharmaceutical, medical compound,
drugs and dealers of chemical, surgical and scientific apparatus and
materials and processing of capsules, syrups, tablets, injectables, aerosols
and ointments and also carries on the business of import, export and as
dealers in all kinds of medicines, pharmaceuticals product drugs, scents and
toilet requisites. |
|
|
|
|
No. of Employees
: |
Information declined by the management. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (48) |
8
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 300000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is well established company in the year 1990, engaged into
pharma business and having satisfactory track record. From the financial for the year ended 2014, company showed decent
turnover of Rs. 620.000 Million and reported top line growth at 11.39%. Its
profitability stood at 3.48 % backed by its debt to equity at 0.15 times. Rating is consideration on company’s established track record of its
business operations supported by its sound financial position and broad
experience of its promoter into pharma sector. Trade relations are reported to be fair. Business is active. Payments
are reported to be regular. In the view of well experienced promoter backed by sound financial
background, company can be considered for business dealing at usual trade
terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
Not Available |
|
Rating |
Not Available |
|
Rating Explanation |
Not Available |
|
Date |
Not Available |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION DENIED BY
|
Name : |
Ms. Anil K Pandey |
|
Designation : |
Not Divulged |
|
Contact No.: |
91-9867364150 |
|
Date : |
21.05.2015 |
LOCATIONS
|
Registered Office/ Factory : |
Plot No.33, Sector-II, The Vasai Taluka Industrial Co-Operative Estate
Limited, Gauripada, Vasai (East), Thane - 401208, Maharashtra, India |
|
Tel. No.: |
91-95250-2455801 / 2452714 / 2453525 |
|
Fax No.: |
91-250-2452074 |
|
E-Mail : |
|
|
Website : |
DIRECTORS
As on 30.09.2014
|
Name : |
Mr. Aziz Abdulhamid Damani |
|
Designation : |
Managing Director |
|
Address : |
Plot No.41/42, Rashid Khamis Road, P. O Box No.23584, Kampala,
Uganda-23584 |
|
Date of Birth/Age : |
12.05.1939 |
|
Date of Appointment : |
20.06.2005 |
|
DIN No.: |
00326536 |
|
|
|
|
Name : |
Ms. Shenaz Aziz Damani |
|
Designation : |
Whole Time Director |
|
Address : |
Plot No.41/42, Rashid Khamis Road, P. O Box No.23584, Kampala,
Uganda-23584 |
|
Date of Birth/Age : |
07.08.1955 |
|
Date of Appointment : |
02.06.2005 |
|
DIN No.: |
00326523 |
|
|
|
|
Name : |
Mr. Anilkumar Anirudh Pandey |
|
Designation : |
Whole Time Director |
|
Address : |
603-B, Silver Presidency, Sector II, Charkop, Kandivali (West), Mumbai
- 400067, Maharashtra, India |
|
Date of Birth/Age : |
29.08.1965 |
|
Date of Appointment : |
30.09.2005 |
|
DIN No.: |
00326828 |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 30.09.2014
|
Names of Shareholders |
No. of Shares |
|
Aziz Abdulhamid Damani |
2500000 |
|
Shenaz Aziz Damani |
499970 |
|
Anilkumar Anirudh Pandey |
150010 |
|
Meera Anilkumar Pandey |
5 |
|
Kamla Anirudh Pandey |
10 |
|
Anamika Anilkumar Pandey |
5 |
|
Total |
3150000 |
As on 30.09.2014
Equity Share Break up (Percentage of Total Equity)
|
Category |
Percentage of Holding |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in the business of chemist, druggists,
importer and manufacturer of and dealers in pharmaceutical, medical compound,
drugs and dealers of chemical, surgical and scientific apparatus and
materials and processing of capsules, syrups, tablets, injectables, aerosols
and ointments and also carries on the business of import, export and as
dealers in all kinds of medicines, pharmaceuticals product drugs, scents and
toilet requisites. |
||||
|
|
|
||||
|
Products : |
|
||||
|
|
|
||||
|
Brand Names : |
Not Divulged |
||||
|
|
|
||||
|
Agencies Held : |
Not Divulged |
||||
|
|
|
||||
|
Exports : |
Not Divulged |
||||
|
|
|
||||
|
Terms : |
Not Divulged |
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
· Dr. Reddy’s Laboratories Limited · Themis Medicare Limited · Ferring Pharmaceutical Private Limited · Strides Arcolab Limited · Brihanmumbai Municipal Corporation · Gittoes Pharmaceuticals Limited · City Mega-Chem Limited · Sungold Pharmaceutical · Rock Chemists Limited · Life Serve Private Limited · Joint Clinical Research Centre(JCRC) |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Information declined by the management. |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
|
|
Auditors : |
|
|
Name : |
S K Shetty and Associates Chartered Accountants |
|
Address : |
D-101, Galaxy Heights, Goregaon Link Road, Opposite Bangur Nagar,
Goregaon (West), Mumbai - 400104, Maharashtra, India |
|
Tel. No.: |
91-22-28799325 |
|
Fax No.: |
91-22-28799326 |
|
E-Mail : |
|
|
Income-tax
PAN of auditor or auditor's firm : |
AALFS5141D |
|
|
|
|
Memberships : |
-- |
|
|
|
|
Collaborators : |
-- |
|
|
|
|
Associates/Subsidiaries
: |
-- |
CAPITAL STRUCTURE
As on 31.03.2014
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
3,150,000 |
Equity Shares |
Rs.10/- each |
Rs. 31.500 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
3,150,000 |
Equity Shares |
Rs.10/- each |
Rs. 31.500
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Million]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders'
Funds |
|
|
|
|
(a) Share Capital |
31.500 |
31.500 |
31.500 |
|
(b) Reserves & Surplus |
57.399 |
35.583 |
25.427 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2)
Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
88.899 |
67.083 |
56.927 |
|
|
|
|
|
|
(3) Non-Current
Liabilities |
|
|
|
|
(a) long-term borrowings |
13.893 |
18.017 |
23.817 |
|
(b) Deferred tax liabilities (Net) |
1.804 |
1.907 |
2.138 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term
provisions |
0.000 |
0.000 |
0.000 |
|
Total Non-current
Liabilities (3) |
15.697 |
19.924 |
25.955 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
0.000 |
6.468 |
23.904 |
|
(b) Trade
payables |
187.775 |
199.263 |
153.891 |
|
(c) Other
current liabilities |
38.544 |
26.781 |
19.679 |
|
(d) Short-term
provisions |
7.674 |
3.155 |
1.286 |
|
Total Current
Liabilities (4) |
233.993 |
235.667 |
198.760 |
|
|
|
|
|
|
TOTAL |
338.589 |
322.674 |
281.642 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
56.674 |
57.836 |
64.041 |
|
(ii)
Intangible Assets |
0.082 |
0.102 |
0.060 |
|
(iii) Capital
work-in-progress |
0.000 |
0.000 |
0.000 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.050 |
0.050 |
0.050 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
0.697 |
0.604 |
0.609 |
|
(e) Other
Non-current assets |
0.052 |
0.052 |
0.052 |
|
Total Non-Current
Assets |
57.555 |
58.644 |
64.812 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
24.385 |
21.988 |
25.047 |
|
(c) Trade
receivables |
126.418 |
142.405 |
125.831 |
|
(d) Cash
and cash equivalents |
15.234 |
10.206 |
2.633 |
|
(e)
Short-term loans and advances |
113.452 |
85.961 |
56.829 |
|
(f) Other
current assets |
1.545 |
3.470 |
6.490 |
|
Total
Current Assets |
281.034 |
264.030 |
216.830 |
|
|
|
|
|
|
TOTAL |
338.589 |
322.674 |
281.642 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
609.395 |
549.091 |
379.835 |
|
|
|
Other Income |
18.287 |
14.370 |
6.661 |
|
|
|
TOTAL (A) |
627.682 |
563.461 |
386.496 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Materials Consumed |
487.046 |
440.179 |
291.331 |
|
|
|
Changes in inventories of finished goods, work-in-progress
and Stock-in-Trade |
(0.067) |
(1.610) |
8.735 |
|
|
|
Employees benefits expense |
17.057 |
14.861 |
12.268 |
|
|
|
Other expenses |
78.842 |
81.173 |
47.666 |
|
|
|
TOTAL (B) |
582.878 |
534.603 |
360.000 |
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION (A-B) (C) |
44.804 |
28.858 |
26.496 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
4.330 |
5.678 |
6.330 |
|
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
40.474 |
23.180 |
20.166 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
7.277 |
7.964 |
8.166 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX (E-F)
(G) |
33.197 |
15.216 |
12.000 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
11.381 |
5.061 |
3.753 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX (G-H) (I) |
21.816 |
10.155 |
8.247 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
563.018 |
512.234 |
346.021 |
|
|
|
Freight Included In The Above Export |
17.968 |
23.014 |
14.545 |
|
|
|
Insurance charges included in above export |
0.725 |
0.639 |
0.400 |
|
|
TOTAL EARNINGS |
581.711 |
535.887 |
360.966 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
86.635 |
76.731 |
47.349 |
|
|
|
Capital Goods |
0.000 |
0.000 |
0.737 |
|
|
TOTAL IMPORTS |
86.635 |
76.731 |
48.086 |
|
|
|
|
|
|
|
|
|
|
Earnings / (Loss)
Per Share (Rs.) |
6.93 |
3.22 |
2.62 |
|
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
PARTICULARS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Current Maturities of Long term debt |
4.574 |
6.500 |
5.400 |
|
Cash generated from operations |
34.842 |
40.784 |
NA |
KEY RATIOS
|
PARTICULARS |
|
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Net Profit Margin |
(%) |
3.58 |
1.85 |
2.17 |
|
|
|
|
|
|
|
Operating Profit Margin |
(%) |
7.35 |
5.26 |
6.98 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
9.81 |
4.72 |
4.26 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.37 |
0.23 |
0.21 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
0.21 |
0.46 |
0.93 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.20 |
1.12 |
1.09 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs. In Million) |
(Rs. In Million) |
(Rs. In Million) |
|
Share Capital |
31.500 |
31.500 |
31.500 |
|
Reserves & Surplus |
25.427 |
35.583 |
57.399 |
|
Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Net worth |
56.927 |
67.083 |
88.899 |
|
|
|
|
|
|
long-term borrowings |
23.817 |
18.017 |
13.893 |
|
Short term borrowings |
23.904 |
6.468 |
0.000 |
|
Current Maturities of
Long Term Debt |
5.400 |
6.500 |
4.574 |
|
Total borrowings |
53.121 |
30.985 |
18.467 |
|
Debt/Equity ratio |
0.933 |
0.462 |
0.208 |
YEAR-ON-YEAR GROWTH
|
Year on Year Growth |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs. In Million) |
(Rs. In Million) |
(Rs. In Million) |
|
Sales |
379.835 |
549.091 |
609.395 |
|
|
|
44.560 |
10.983 |
NET PROFIT MARGIN
|
Net Profit Margin |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs. In Million) |
(Rs. In Million) |
(Rs. In Million) |
|
Sales |
379.835 |
549.091 |
609.395 |
|
Profit |
8.247 |
10.155 |
21.816 |
|
|
2.17% |
1.85% |
3.58% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
No |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
No |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
No |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
INDEX OF CHARGES
|
S.NO. |
CHARGE ID |
DATE OF CHARGE
CREATION/MODIFICATION |
CHARGE AMOUNT
SECURED |
CHARGE HOLDER |
ADDRESS |
SERVICE REQUEST
NUMBER (SRN) |
|
1 |
10085418 |
14/02/2012 * |
94,600,000.00 |
STATE BANK OF INDIA |
INDUSTRIAL FINANCE BRANCH, S.V. ROAD, MALAD WEST, |
B36620516 |
|
2 |
90186550 |
18/03/1998 |
6,000,000.00 |
THE BHARAT CO-OP. BANK LTD. |
ANDHERI EAST BRANCH; B - 28; MITTAL INDU. ESTATE, |
- |
|
3 |
90186012 |
30/12/1993 |
1,000,000.00 |
DEVELOPMENT CO-OP BANK LTD. |
JOGESHWARI WEST, MUMBAI, MAHARASHTRA - 400103, IND |
- |
|
4 |
90189106 |
26/12/1992 |
2,800,000.00 |
DEVELOPMENT CO-OP BANK LTD. |
JOGESHWARI WEST, MUMBAI, MAHARASHTRA - 400103, IND |
- |
* Date of charge modification
UNSECURED LOANS
|
PARTICULAR |
31.03.2014 (Rs.
In Million) |
31.03.2013 (Rs.
In Million) |
|
LONG TERM
BORROWINGS |
|
|
|
Loans and Advances
from related parties Aziz A. Damani |
13.893 |
13.893 |
|
Total |
13.893 |
13.893 |
CHANGE OF ADDRESS
The Registered office has been shifted from A-21, New Empire Industrial
Estate, Kondivita Lane, J B Nagar, Andheri (East), Mumbai - 400059,
Maharashtra, India to the present address w.e.f. 02.06.2006.
CORPORATE INFORMATION
Subject is a limited company registered under the Companies Act, 1956 it was incorporated on 22nd day of June 1995, it is engaged to carryout the business of chemist, druggists, importers and manufacturers of and dealers in pharmaceutical, medical compound, drugs and dealers of chemical, surgical and scientific apparatus and materials and processing of capsules, syrups, tablets, injectables, aerosols and ointments. It also carries on the business of import, export and as dealers in all kinds of medicines, pharmaceuticals product drugs, scents and toilet requisites. The principal place of business is in Thane.
WORKING RESULTS
The directors are happy to inform, that during the year, the Company has turned the corner and had earned a Net Profit of Rs. 21.816 Million after providing Depreciation of Rs. 7.277 Million (Previous Year Rs. 7.964 Million), provision for Taxation of Rs. 11.484 Million (Previous Year - Rs. 5.353 Million), and Deferred Tax of (Rs.0.103 Million) (Previous Year - Rs. (Rs. 0.231 Million) and adding excess provision of income Tax for the A. Y 2010 - 201 I of Rs. NIL (Previous Year - Rs. 0.062 Million) as against the Net Profit of Rs. 10.155 Million over the Previous Year.
FIXED ASSETS
Tangible Assets
· Leasehold Land
· Computer
· Factory Building
· Plant and Machinery
· Furniture and Fixtures
· Office Equipments
· Electricity Installation
Intangible Assets
· Goodwill
· Software
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market survey
revealed that the amount of compensation sought by the subject is fair and
reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.57 |
|
|
1 |
Rs.99.67 |
|
Euro |
1 |
Rs.70.93 |
INFORMATION DETAILS
|
Information
Gathered by : |
PRT |
|
|
|
|
Analysis Done by
: |
KSH |
|
|
|
|
Report Prepared
by : |
SNT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
----- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
48 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial condition
(40%) Ownership background
(20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.